Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin for prevention of recurrent genital warts
ChiCTR-IPR-15006912Phase 4Not yet recruiting
- Sponsor
- The first affiliated hospiral, Shantou University Medical College
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin in anogenital warts (2 arms), sponsored by The first affiliated hospiral, Shantou University Medical College. Primary endpoint: Recurrence rate. Planned start Aug 2013; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
anogenital warts
Beyond the preview
Go deeper on ChiCTR-IPR-15006912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006912.